RADIOLOGICAL AND NUCLEAR PREPAREDNESS ADVANCEMENTS
Read about innovation through tissue chip technology, platelet refrigeration, and more
Enhancing the Nation's PUBLIC HEALTH SECURITY and emergency preparedness by facilitating communication on innovative products and solutions between federal agencies and public stakeholders.
WATCH: FIRESIDE CHAT
with the ASPR, Dawn O'Connell, and BARDA Director, Dr. Gary Disbrow
Hear their vision on how ASPR & BARDA can assist in strengthening our medical countermeasure supply chains, manufacturing capacity and leveraging BARDA's innovation networks to prepare for future threats
BARDA provides a systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies.
ASPR focuses on preparedness planning and response; building federal emergency medical operational capabilities; countermeasures research, and grants to strengthen the capabilities of health care systems to minimize the health impacts of public health emergencies.
NIH is responsible for conducting research to better understand public health threats and establish a foundation for developing medical countermeasures.
FDA's responsibility is to ensure that medical countermeasures (MCMs)-such as drugs, vaccines, and diagnostic tests-to counter these threats are safe, effective, and secure.
The CDC leads the emergency preparedness and response activities by providing strategic coordination for activities across local, state, national, and international public health partners.
The DHS is charged with securing the nation from the many threats we face. These threats include natural and man-made biological, chemical, radiological, and nuclear threats.